Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Lexeo Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · New York, NY, United States

  1. PrincipalsEric AdlerChief Medical OfficerJenny RobertsonChief Legal OfficerJose Manuel OteroChief Operating Officerand 4 more
  2. CompanyLexeo Therapeutics, Inc.New York, NY, United States
  3. Phone line+1 (212) 547-9879General business
Request a quote

Lexeo Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker LXEO) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 7

Chief executive

Richard Nolan TownsendChief Executive Officer

Finance

Louis Edward TamayoChief Financial Officer

Operations

Jose Manuel OteroChief Operating Officer

Legal

Jenny RobertsonChief Legal Officer
Everyone else on file (3)
Eric AdlerChief Medical Officer
Narinder Pal BhallaChief Medical Officer
Tai Sandi SeeChief Development Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Louis Edward Tamayo — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Eric Adler — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Jenny Robertson — Chief Legal Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Jose Manuel Otero — Chief Operating Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers